Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues

Xenobiotica

Volumn 42, Issue 3, 2012, Pages 266-277

  Court, Michael H ^a   Zhang, Xiuling ^b   Ding, Xinxin ^b   Yee, Karen K ^c   Hesse, Leah M ^a   Finel, Moshe ^d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WADSWORTH CENTER   (United States)

^c MONELL CHEMICAL SENSES CENTER   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Glucuronidation; UDP glucuronosyltransferase; UGT

Indexed keywords

BETA ACTIN; GLUCURONOSYLTRANSFERASE; MESSENGER RNA; RNA; RNA 18S; URIDINE DIPHOSPHATE GLUCURONIC ACID;

ADIPOSE DERIVED STEM CELL; ADRENAL GLAND; ADULT; ARTICLE; BONE MARROW; BRAIN; BREAST; CEREBELLUM; CLINICAL ARTICLE; COLON; FETUS; GENE EXPRESSION; GLUCURONIDATION; HEART; HUMAN; HUMAN TISSUE; LIVER; LUNG; NOSE MUCOSA; OVARY; PANCREAS; PLACENTA; PROSTATE; REAL TIME POLYMERASE CHAIN REACTION; SALIVARY GLAND; SKELETAL MUSCLE; SMALL INTESTINE; SPLEEN; STOMACH; TESTIS; THYMUS; THYROID GLAND; TISSUE DISTRIBUTION; TRACHEA; UTERUS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONOSYLTRANSFERASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; ORGAN SPECIFICITY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 84863042741     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2011.618954     Document Type: Article

References (38)

1. Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, Kuipers F, Kosykh V, Fruchart JC, Staels B. (2003). FXR induces the UGT2B4 enzyme in hepatocytes: A potential mechanism of negative feedback control of FXR activity. Gastroenterology 124:1926-1940. (Pubitemid 36666787)
2. Coughtrie MW, Burchell B, Leakey JE, Hume R. (1988). The inadequacy of perinatal glucuronidation: Immunoblot analysis of the developmental expression of individual UDPglucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol 34:729-735. (Pubitemid 19014393)
3. Courillon F, Gerhardt MF, Myara A, Daffos F, Forestier F, Trivin F. (1998). Serum C24 bile acids in the developing human fetus. Biol Neonate 73:76-88. (Pubitemid 28045127)
4. Court MH, Krishnaswamy S, Hao Q, Duan SX, Patten CJ, Von Moltke LL, Greenblatt DJ. (2003). Evaluation of 3?-azido-3?-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: Specificity and influence of the UGT2B72 polymorphism. Drug Metab Dispos 31:1125-1133. (Pubitemid 37048284)
5. Court MH. (2005). Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Meth Enzymol 400:104-116. (Pubitemid 43052418)
6. Court MH, Hazarika S, Krishnaswamy S, Finel M, Williams JA. (2008). Novel polymorphic human UDP-glucuronosyltransferase (UGT) 2A3: Cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Mol Pharmacol 74:744-754.
7. Court MH. (2010). Inter-individual variability in hepatic drug glucuronidation: Studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 42:209-224.
8. Guillemette C, Lévesque E, Harvey M, Bellemare J, Menard V. (2010). UGT genomic diversity: Beyond gene duplication. Drug Metab Rev 42:24-44.
9. Itäaho K, Court MH, Uutela P, Kostiainen R, Radominska-Pandya A, Finel M. (2009). Dopamine is a low-affinity and high-specificity substrate for the human UDP-glucuronosyltransferase 1A10. Drug Metab Dispos 37:768-775.
10. Izukawa T, Nakajima M, Fujiwara R, Yamanaka H, Fukami T, Takamiya M, Aoki Y, Ikushiro S, Sakaki T, Yokoi T. (2009). Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug Metab Dispos 37:1759-1768.
11. Jedlitschky G, Cassidy AJ, Sales M, Pratt N, Burchell B. (1999). Cloning and characterization of a novel human olfactory UDPglucuronosyltransferase. Biochem J 340:837-843. (Pubitemid 29312884)
12. Jemnitz K, Heredi-Szabo K, Janossy J, Ioja E, Vereczkey L, Krajcsi P. (2010). ABCC2/Abcc2: A multispecific transporter with dominant excretory functions. Drug Metab Rev 42:402-436.
13. Jeong EJ, Liu X, Jia X, Chen J, Hu M. (2005). Coupling of conjugating enzymes and efflux transporters: Impact on bioavailability and drug interactions. Curr Drug Metab 6:455-468. (Pubitemid 41300790)
14. Jin CJ, Mackenzie PI, Miners JO. (1997). The regio-and stereoselectivity of C19 and C21 hydroxysteroid glucuronidation by UGT2B7 and UGT2B11. Arch Biochem Biophys 341:207-211. (Pubitemid 27203023)
15. Kaivosaari S, Toivonen P, Hesse LM, Koskinen M, Court MH, Finel M. (2007). Nicotine glucuronidation and the human UDPglucuronosyltransferase UGT2B10. Mol Pharmacol 72:761-768. (Pubitemid 47347311)
16. Karlen Y, McNair A, Perseguers S, Mazza C, Mermod N. (2007). Statistical significance of quantitative PCR. BMC Bioinformatics 8:131.
17. Laakkonen L, Finel M. (2010). A molecular model of the human UDPglucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme. Mol Pharmacol 77:931-939.
18. Lazard D, Zupko K, Poria Y, Nef P, Lazarovits J, Horn S, Khen M, Lancet D. (1991). Odorant signal termination by olfactory UDP glucuronosyl transferase. Nature 349:790-793. (Pubitemid 21912166)
19. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-685. (Pubitemid 41345319)
20. Mahone PR, Scott K, Sleggs G, D'Antoni T, Woods JR Jr. (1994). Cocaine and metabolites in amniotic fluid may prolong fetal drug exposure. Am J Obstet Gynecol 171:465-469. (Pubitemid 24279234)
21. Manevski N, Kurkela M, Höglund C, Mauriala T, Court MH, Yli-Kauhaluoma J, Finel M. (2010). Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. Drug Metab Dispos 38:386-395.
22. Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, Yokoi T. (2008). Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461-1464.
23. Nishimura M, Naito S. (2006). Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab Pharmacokinet 21:357-374.
24. Ohno S, Nakajin S. (2009). Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptasepolymerase chain reaction. Drug Metab Dispos 37:32-40.
25. Pillot T, Ouzzine M, Fournel-Gigleux S, Lafaurie C, Radominska A, Burchell B, Siest G, Magdalou J. (1993). Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem 268:25636-25642. (Pubitemid 23358174)
26. Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, Mackenzie PI. (1999). Structural and functional studies of UDPglucuronosyltransferases. Drug Metab Rev 31:817-899.
27. Shoda J, Mahara R, Osuga T, Tohma M, Ohnishi S, Miyazaki H, Tanaka N, Matsuzaki Y. (1988). Similarity of unusual bile acids in human umbilical cord blood and amniotic fluid from newborns and in sera and urine from adult patients with cholestatic liver diseases. J Lipid Res 29:847-858.
28. Sneitz N, Court MH, Zhang X, Laajanen K, Yee KK, Dalton P, Ding X, and Finel M. (2009). Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A. Pharmacogenet Genomics 19:923-934.
29. Somers GI, Lindsay N, Lowdon BM, Jones AE, Freathy C, Ho S, Woodrooffe AJ, Bayliss MK, Manchee GR. (2007). A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes. Drug Metab Dispos 35:1797-1805. (Pubitemid 47481571)
30. Strassburg CP, Strassburg A, Kneip S, Barut A, Tukey RH, Rodeck B, Manns MP. (2002). Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50:259-265. (Pubitemid 34087942)
31. Tchernof A, Levesque E, Beaulieu M, Couture P, Despres JP, Hum DW, Belanger A. (1999). Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method. Clin Endocrinol 50:637-642. (Pubitemid 29236341)
32. Tukey RH, Strassburg CP. (2000). Human UDPglucuronosyltransferases: Metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616. (Pubitemid 30340694)
33. Tukey RH, Strassburg CP. (2001). Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol Pharmacol 59:405-414. (Pubitemid 32179916)
34. Turgeon D, Carrier JS, Levesque E, Hum DW, Belanger A. (2001). Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787. (Pubitemid 32222427)
35. Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Chowdhury NR, Ritter JK. (2004). Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 32:281-290. (Pubitemid 38263885)
36. Wilson W 3rd, Pardo-Manuel de Villena F, Lyn-Cook BD, Chatterjee PK, Bell TA, Detwiler DA, Gilmore RC, Valladeras IC, Wright CC, Threadgill DW, Grant DJ. (2004). Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. Genomics 84:707-714. (Pubitemid 39310948)
37. Xue Y, Sun D, Daly A, Yang F, Zhou X, Zhao M, Huang N, Zerjal T, Lee C, Carter NP, Hurles ME, Tyler-Smith C. (2008). Adaptive evolution of UGT2B17 copy-number variation. Am J Hum Genet 83:337-346.
38. Zhou D, Guo J, Linnenbach AJ, Booth-Genthe CL, Grimm SW. (2010). Role of human UGT2B10 in N-glucuronidation of tricyclic antidepressants, amitriptyline, imipramine, clomipramine, and trimipramine. Drug Metab Dispos 38:863-870.